The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement

Kent, David M., Paulus, Jessica K., van Klaveren, David, D'Agostino, Ralph, Goodman, Steve, Hayward, Rodney, Ioannidis, John P.A., Patrick-Lake, Bray, Morton, Sally, Pencina, Michael, Raman, Gowri, Ross, Joseph S., Selker, Harry P., Varadhan, Ravi, Vickers, Andrew, Wong, John B., Steyerberg, Ewout W.·2020·Annals of Internal Medicine

DOI 10.7326/m18-3667

Cited by (474)

Items 101–200 of 474

Body Mass Index and Cause-Specific Mortality after Lung Transplantation in the United States
Michaela Restivo Anderson, Ed Cantu, Michael G. S. Shashaty, Luke J. Benvenuto, Laurel Kalman, Scott M. Palmer, Jonathan Paul Singer, Robert Gallop, Joshua Matthew Diamond, Jesse Y. Hsu et al. · 2023 · Annals of the American Thoracic Society
Arthroplasty Versus Internal Fixation for the Treatment of Undisplaced Femoral Neck Fractures: A Retrospective Cohort Study
Shaikh Afaq, Nathan N. O’Hara, Emil H. Schemitsch, Sofia Bzovsky, Sheila Sprague, Rudolf Wilhelm Poolman, Frede Frihagen, Diane Heels‐Ansdell, Mohit Bhandari, Marc F. Swiontkowski et al. · 2020 · Journal of Orthopaedic Trauma
Can Machine Learning from Real-World Data Support Drug Treatment Decisions? A Prediction Modeling Case for Direct Oral Anticoagulants
Andreas Daniel Meid, Lucas Wirbka, ARMIN Study Group, Andreas Groll, Walter E. Haefeli · 2021 · Medical Decision Making
Predictive Modeling of Heterogeneous Treatment Effects in RCTs
Joe V. Selby, Carolien C. H. M. Maas, BRUCE H. FIREMAN, David M. Kent · 2025 · JAMA Network Open
Supervised Resistance Training on Functional Capacity, Muscle Strength and Vascular Function in Peripheral Artery Disease: An Updated Systematic Review and Meta-Analysis
Elizabeth Ellen Blears, Jessica K. Elias, Christian Tapking, Craig C. Porter, Victoria G. Rontoyanni · 2021 · Journal of Clinical Medicine
Expanding Evidence for Clinical Care of Older Adults
Michael Alan Steinman, Cynthia M. Boyd, Kenneth E. Schmader · 2021 · JAMA
Personalizing treatment in end-stage kidney disease: deciding between haemodiafiltration and haemodialysis based on individualized treatment effect prediction
Rob C.M. van Kruijsdijk, Robin W.M. Vernooij, Michiel L. Bots, Sanne A. E. Peters, Jannick A N Dorresteijn, Frank L.J. Visseren, Peter J. Blankestijn, Thomas P. A. Debray, The HDF Pooling Project investigators, Michiel L. Bots et al. · 2022 · Clinical Kidney Journal
Evaluating individualized treatment effect predictions: A model‐based perspective on discrimination and calibration assessment
Jeroen Hoogland, Orestis Efthimiou, Tri‐Long Nguyen, Thomas P. A. Debray · 2024 · Statistics in Medicine
Toward Precision in Critical Care Research: Methods for Observational and Interventional Studies
Emma J. Graham Linck, Ewan C. Goligher, Matthew W. Semler, Matthew M. Churpek · 2024 · Critical Care Medicine
Balanced crystalloid versus saline for resuscitation in pediatric septic shock: a systematic review and meta-analysis
Barkhá Vijendra, Ana Beatriz Bertol, Mylena Maria Guedes de Almeida, Pedro Henrique Aquino Gil de Freitas, Áurea Maria Salomão Simão, Bianca Lisa de Faria · 2025 · BMC Pediatrics
GLP-1RA precision medicine in people with type 2 diabetes: current insights and future prospects
Pedro Cardoso, John Dennis, Ewan R. Pearson · 2026 · Journal of Clinical Investigation
Microvascular Disease and Risk of Cardiovascular Events and Death From Intensive Treatment in Type 2 Diabetes
David E. Kloecker, Kamlesh Khunti, Melanie Jane Davies, Dario Pitocco, Francesco Zaccardi · 2021 · Mayo Clinic Proceedings
Therapeutic trials in difficult to treat steroid sensitive nephrotic syndrome: challenges and future directions
Ashlene Maree McKay, Rulan Savita Parekh, Damien Gerard Noone · 2022 · Pediatric Nephrology
Establishing a Gold Standard for Noninvasive Identification of Painful Lumbar Discs: Prospective Comparison of Magnetic Resonance Spectroscopy vs Low-Pressure Provocation Discography
Matthew F. Gornet, James C. Peacock, Timothy Charles Ryken, Francine W. Schranck, Robert K. Eastlack, Jeffrey C. Lotz · 2024 · The International Journal of Spine Surgery
Annals Clinical Decision Making: Translating Population Evidence to Individual Patients
Katrina Armstrong, Joshua P. Metlay · 2020 · Annals of Internal Medicine
Missing the trees for the forest: most subgroup analyses using forest plots at the ASCO annual meeting are inconclusive
Andrew Warren Hahn, Nazlı Dizman, Pavlos Msaouel · 2022 · Therapeutic Advances in Medical Oncology
Leveraging machine learning predictive biomarkers to augment the statistical power of clinical trials with baseline magnetic resonance imaging
Carolyn Lou, Mohamad Habes, Nicholas Illenberger, Ali Ezzati, Richard B. Lipton, Pamela A. Shaw, Alisa J. Stephens‐Shields, Hamed Akbari, Jimit J. Doshi, Christos A. Davatzikos et al. · 2021 · Brain Communications
Predicting Treatment Responses in Patients With Osteoarthritis: Results From Two Phase III Tanezumab Randomized Clinical Trials
Luana Colloca, Robert H. Dworkin, John T. Farrar, Leslie A. Tive, Jiyue Yang, Lars Viktrup, Gorana Dašić, Christine R. West, Ed Whalen, M. Brown et al. · 2023 · Clinical Pharmacology & Therapeutics
Estimating individualized treatment effects from randomized controlled trials: a simulation study to compare risk-based approaches
Alexandros Rekkas, Peter R. Rijnbeek, David M. Kent, Ewout Willem Steyerberg, David V. Klaveren · 2023 · BMC Medical Research Methodology
Covariate adjustment in subgroup analyses of randomized clinical trials: A propensity score approach
Siyun Yang, Fan Li, Laine Elliott Thomas, Fan Li · 2021 · Clinical Trials
Single case designs for early phase behavioral translational research in health psychology.
Leonard H. Epstein, Warren Kurt Bickel, Susan M. Czajkowski, Rocco A. Paluch, Mariola Moeyaert, Karina W. Davidson · 2021 · Health Psychology
Daily practice in guideline adherence to adjuvant chemotherapy in stage III colon cancer and predictors of outcome
Inge van den Berg, Simone van de Weerd, David V. Klaveren, Robert R.J. Coebergh van den Braak, J. Han van Krieken, Miriam Koopman, Jeanine M.L. Roodhart, Jan Paul Medema, Jan N.M. IJzermans · 2021 · European Journal of Surgical Oncology
Heterogeneity in the response to a high vs low mean arterial pressure target in patients with septic shock a post hoc analysis of a randomized controlled trial
Romain Pirracchio, Nicholas Fong, Matthieu M. Legrand · 2025 · Intensive Care Medicine
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis
Leon Di Stefano, Elizabeth L. Ogburn, Malathi Ram, Daniel O. Scharfstein, Tianjing Li, Preeti Khanal, Sheriza N. Baksh, Nichol A. McBee, Joshua B. Gruber, Marianne Reid Gildea et al. · 2022 · PLoS ONE
A heart failure phenotype stratified model for predicting 1-year mortality in patients admitted with acute heart failure: results from an individual participant data meta-analysis of four prospective European cohorts
Yuntao Chen, Adriaan A. Voors, Tiny Jaarsma, Chim Choy Lang, Iziah Edwin Sama, K. Martijn Akkerhuis, Eric H. Boersma, Hans L. Hillege, Douwe Postmus · 2021 · BMC Medicine
New Directions in Research on Heterogeneity of Treatment Effects for Major Depression
Alex R. Luedtke, Ronald C. Kessler · 2021 · JAMA Psychiatry
Estimating and Evaluating Counterfactual Prediction Models
Christopher Boyer, Issa J Dahabreh, Jon Arni Steingrimsson · 2025 · Statistics in Medicine
An individualized treatment rule to optimize probability of remission by continuation, switching, or combining antidepressant medications after failing a first-line antidepressant in a two-stage randomized trial
Ronald C. Kessler, Toshi A. Furukawa, Tadashi Kato, Alex R. Luedtke, Maria V. Petukhova, Ekaterina Sadikova, Nancy A. Sampson · 2021 · Psychological Medicine
Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial
Loren K. Mell, Stephanie L. Pugh, Christopher Uwe Jones, Tyler J. Nelson, Kaveh Zakeri, Brent Shane Rose, Kenneth Lee Zeitzer, Elizabeth Gore, Jean-Paul Bahary, Luís Souhami et al. · 2023 · European Urology
Emerging Analytical Approaches for Personalized Medicine Using Machine Learning In Pediatric and Congenital Heart Disease
Bhargava Kumar Chinni, Cedric Manlhiot · 2024 · Canadian Journal of Cardiology
Covariate Selection for Estimating Individual Treatment Effects in Psychotherapy Research: A Simulation Study and Empirical Example
Robin Anno Wester, Julian A. Rubel, Axel Mayer · 2022 · Clinical Psychological Science
Impervious to Randomness: Confounding and Selection Biases in Randomized Clinical Trials
Pavlos Msaouel · 2021 · Cancer Investigation
Five tenets for advancing evidence-based precision medicine
Daniel Coral, Jennifer L Sargent, Julia Carrasco-Zanini, Luis Coral, Aaron J. Deutsch, Miriam S. Udler, Giuseppe N. Giordano, G P Pare, Ewan R. Pearson, Maarten van Smeden et al. · 2026 · Nature Medicine
An Electronic Health Record–Compatible Model to Predict Personalized Treatment Effects From the Diabetes Prevention Program: A Cross-Evidence Synthesis Approach Using Clinical Trial and Real-World Data
David M. Kent, Jason Nelson, Anastassios G. Pittas, Francis R. Colangelo, Carolyn Koenig, David V. Klaveren, Elizabeth L. Ciemins, John K. Cuddeback · 2021 · Mayo Clinic Proceedings
Can Systems Biology Advance Clinical Precision Oncology?
Andrea Rocca, Boris Ν. Kholodenko · 2021 · Cancers
Heterogeneity of Treatment Effects of Hydrocortisone by Risk of Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants in the National Institute of Child Health and Human Development Neonatal Research Network Trial
Samuel J. Gentle, Matthew A. Rysavy, Lei Li, Matthew Maxwell Laughon, Ravi M. Patel, Erik A. Jensen, Susan R. Hintz, Namasivayam Ambalavanan, Waldemar A. Carlo, Kristi L. Watterberg et al. · 2023 · JAMA Network Open
Integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial
Emmy M. Trinks-Roerdink, Geert‐Jan Geersing, Carline J. van den Dries, Martin E W Hemels, Michiel Rienstra, Isabelle C. Van Gelder, Maarten van Smeden, David V. Klaveren, David M. Kent, Frans Hendrik Rutten et al. · 2023 · PLoS ONE
Decision curve analysis based on summary data
Iztok Hozo, Gordon Henry Guyatt, Benjamin Djulbegović · 2023 · Journal of Evaluation in Clinical Practice
Risk-stratified thromboprophylaxis effects of aspirin versus low-molecular-weight heparin in orthopedic trauma patients: A secondary analysis of the PREVENT CLOT trial
Nathan N. O’Hara, Robert V. O’Toole, Katherine P. Frey, Renan C. Castillo, Joseph Cuschieri, Elliott Richard Haut, Gerard P. Slobogean, Reza Firoozabadi, Ashley Britton Christmas, William Todd Obremskey et al. · 2023 · The Journal of Trauma: Injury, Infection, and Critical Care
Heterogeneity of treatment response to beta-blockers in the treatment of portal hypertension: A systematic review
Mohammad Alsaeid, Shuen Sung, Wayne Bai, Matthew Tam, Yu Jun Wong, Jordi Cortés, Erik Cobo, José Antonio González, Juan G. Abraldeṣ · 2024 · Hepatology Communications
Machine-learning approaches to predict individualized treatment effect using a randomized controlled trial
Rikuta Hamaya, Konan Hara, JoAnn Elisabeth Manson, Eric B. Rimm, Frank M. Sacks, Qiaochu Xue, Lu Qi, Nancy R. Cook · 2025 · European Journal of Epidemiology
Individualized Net Benefit of Intensive Blood Pressure Lowering Among Community‐Dwelling Older Adults in SPRINT
Mitra S. Jamshidian, Rebecca Scherzer, Michelle M. Estrella, Richard L. Kravitz, Rebecca S. Boxer, Daniel Joseph Tancredi, Jarett D. Berry, James A. de Lemos, Charles Ginsberg, Joachim H. Ix et al. · 2025 · Journal of the American Geriatrics Society
Assessing heterogeneity of treatment effect in multiple sclerosis trials
Maria Pia Sormani, Jeremy Chataway, David M. Kent, Ruth Ann Marrie · 2023 · Multiple Sclerosis Journal
Sodium Correction Rates and Associated Outcomes Among Patients With Severe Hyponatremia
Dustin G. Mark, Mubarika Alavi, Joshua R. Nugent, Mary E. Reed, Kaiser Permanente CREST Network Investigators, David R. Vinson, Dustin W. Ballard, Dana R. Sax, Mamata V. Kene · 2026 · Annals of Internal Medicine
Do machine learning methods lead to similar individualized treatment rules? A comparison study on real data
Florie Brion Bouvier, Etienne Peyrot, Alan Balendran, Corentin Ségalas, Ian Roberts, François Petit, Raphaël Porcher · 2024 · Statistics in Medicine
Standardization and Prediction to Control Confounding: Estimating Risk Differences and Ratios for Clinical Interpretations and Decision Making
A. Russell Localio, James A. Henegan, Stephanie Chang, Anne R. Meibohm, Eric A. Ross, Steven N. Goodman, David J. Couper, Eliseo Güallar, Michael E Griswold · 2025 · Annals of Internal Medicine
Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC
Maliazurina Binti Saad, Qasem Al-Tashi, Lingzhi Hong, Vivek Verma, Wentao Li, Daniel Boiarsky, Shenduo Li, Milena Petranović, Carol C. Wu, Brett W. Carter et al. · 2025 · Nature Communications
Optimizing opioid use disorder treatment with naltrexone or buprenorphine
Kara E. Rudolph, Ivan Matos Diaz, Sean X. Luo, John Rotrosen, Edward V. Nunes · 2021 · Drug and Alcohol Dependence
Tocilizumab in COVID-19 – A Bayesian reanalysis of RECOVERY
Arthur M. Albuquerque, Lucas Tramujas, Lorenzo R. Sewanan, James M. Brophy · 2021 · medRxiv
Toward a causal model of chronic back pain: Challenges and opportunities
John Russell Huie, Rohit Vashisht, Anoop Raj Galivanche, Constance Hadjadj, Saam Morshed, Atul Janardhan Butte, Adam R. Ferguson, Conor O'Neill · 2023 · Frontiers in Computational Neuroscience
Incorporating Individual‐Level Treatment Effects and Outcome Preferences Into Personalized Blood Pressure Target Recommendations
Simon B. Ascher, Richard L. Kravitz, Rebecca Scherzer, Jarett D. Berry, James A. de Lemos, Michelle M. Estrella, Daniel Joseph Tancredi, Anthony A. Killeen, Joachim H. Ix, Michael G. Shlipak · 2024 · Journal of the American Heart Association
Cardiovascular effectiveness of newer glucose-lowering agents, with and without baseline lipid-lowering therapy in type 2 diabetes: A systematic meta-analysis of cardiovascular outcome trials and real-world evidence
Setor Kwadzo Kunutsor, Borenyi S. Seidu, Samuel Seidu · 2024 · Primary care diabetes
The definition of predictor and outcome variables in mortality prediction models: a scoping review and quality of reporting study
Eline G. M. Cox, Daniek A. M. Meijs, Laure Wynants, Jan-Willem E. M. Sels, Jacqueline Koeze, Frederik Keus, Bianca Bos-van Dongen, Iwan C.C. van der Horst, Iwan C.C. van der Horst · 2024 · Journal of Clinical Epidemiology
Identifying heterogeneity of treatment effect for antibiotic duration in bloodstream infection: an exploratory post-hoc analysis of the BALANCE randomised clinical trial
Sean Wei Xiang Ong, Ruxandra L Pinto, Asgar H. Rishu, Steven Y. C. Tong, Robert J. Commons, John Maynard Conly, Gerald A. Evans, Michael Fralick, Christopher E. Kandel, Philippe R. S. Lagacé-Wiens et al. · 2025 · EClinicalMedicine
Targeting of the diabetes prevention program leads to substantial benefits when capacity is constrained
Natalia Olchanski, David V. Klaveren, Joshua T. Cohen, John B. Wong, Robin Ruthazer, David M. Kent · 2021 · Acta Diabetologica
Generalised decision curve analysis for explicit comparison of treatment effects
Iztok Hozo, Benjamin Djulbegović · 2023 · Journal of Evaluation in Clinical Practice
A new method for clustered survival data: Estimation of treatment effect heterogeneity and variable selection
Liangyuan Hu · 2023 · Biometrical Journal
Dirichlet process mixture models to impute missing predictor data in counterfactual prediction models: an application to predict optimal type 2 diabetes therapy
Pedro Cardoso, John Dennis, Jack Bowden, Beverley M. Shields, Trevelyan J. McKinley · 2024 · BMC Medical Informatics and Decision Making
Integration of an Objective Cognitive Assessment Into a Prognostic Index for 5‐Year Mortality Prediction
Ashwin Kotwal, Sei J. Lee, William Dale, W. John Boscardin, Linda J. Waite, Alexander Kingsbury Smith · 2020 · Journal of the American Geriatrics Society
Simple Methods for Evaluating 4 Types of Biomarkers: Surrogate Endpoint, Prognostic, Predictive, and Cancer Screening
Stuart G. Baker, Barnett S. Kramer · 2020 · Biomarker Insights
Optimally Choosing Medication Type for Patients With Opioid Use Disorder
Kara E. Rudolph, Nicholas Williams, Ivan Matos Diaz, Sean X. Luo, John Rotrosen, Edward V. Nunes · 2022 · American Journal of Epidemiology
Evaluating Therapies to Prevent Future Stroke in Patients with Patent Foramen Ovale-Related Strokes – The SCOPE Study
David M. Kent, Jeffrey L. Saver, Scott Eric Kasner, Jason Nelson, Andy Yu-Der Wang, Raveendhara R. Bannuru, John Carroll, Gilles Châtellier, Geneviève Dérumeaux, Anthony J. Furlan et al. · 2023
Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention
Kathleen V. Fitch, Markella V. Zanni, Jennifer Manne‐Goehler, Marissa R Diggs, Arijeet K. Gattu, Judith S. Currier, Gerald S. Bloomfield, Chiu-Bin Hsiao, Samir Kumar Gupta, Judith A. Aberg et al. · 2024 · Annals of Internal Medicine
Cardiovascular and kidney benefits of SGLT-2is and GLP-1RAs according to baseline blood pressure in type 2 diabetes: a systematic meta-analysis of cardiovascular outcome trials
Setor Kwadzo Kunutsor, Samuel Seidu, Richard S. Dey, Isaac K. Baidoo, Abderrahim Oulhaj · 2024 · Scandinavian Cardiovascular Journal
Estimated Population Health Benefits of Intensive Systolic Blood Pressure Treatment Among SPRINT-Eligible US Adults
Catherine G. Derington, Adam Phillip Bress, Ransmond O. Berchie, Jennifer S. Herrick, Jincheng Shen, Jian Ying, Tom Greene, Gabriel S. Tajeu, Swati Sakhuja, Natalia Ruiz‐Negrón et al. · 2023 · American Journal of Hypertension
Methods for Integrating Trials and Non-experimental Data to Examine Treatment Effect Heterogeneity
Carly Lupton‐Smith, Ting-Hsuan Chang, Trang Quynh Nguyen, Hwanhee Hong, Leon Di Stefano, Elizabeth A. Stuart · 2023 · Statistical Science
Identifying Veterans Who Benefit From Nirmatrelvir-Ritonavir: A Target Trial Emulation
Lei Yan, David Pham Bui, Yuli Li, Nallakkandi Rajeevan, Mazhgan Rowneki, Kristin Berry, Stephanie Argraves, Yuan Huang, Denise M. Hynes, Francesca E. Cunningham et al. · 2024 · Clinical Infectious Diseases
Subgroup analyses and heterogeneity of treatment effects in randomized trials: a primer for the clinician
Alexandra B. Spicer, Alexandre Biasi Cavalcanti, Fernando Godinho Zampieri · 2024 · Current Opinion in Critical Care
A classification of methods used to personalize participative interventions revealed inadequate reporting in trial protocols
Alexandre Malmartel, Philippe Ravaud, Lina Ghosn, Viet-Thi Tran · 2021 · Journal of Clinical Epidemiology
A permutation procedure to detect heterogeneous treatment effects in randomized clinical trials while controlling the type I error rate
Jack M. Wolf, Joseph S. Koopmeiners, David M. Vock · 2022 · Clinical Trials
The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement
Stuart G. Baker · 2020 · Annals of Internal Medicine
Principled estimation and evaluation of treatment effect heterogeneity: A case study application to dabigatran for patients with atrial fibrillation
Yizhe Xu, Katelyn Bechler, Alison Callahan, Nigam Haresh Shah · 2023 · Journal of Biomedical Informatics
Personalized glucose-lowering effect of chiglitazar in type 2 diabetes
Qi Huang, Xiantong Zou, Yingli Chen, Leili Gao, Xiaoling Cai, Lingli Zhou, Fei Gao, Jian Zhou, Weiping Jia, Linong Ji · 2023 · iScience
Advancing randomized controlled trial methodologies: The place of innovative trial design in eating disorders research
Elizabeth Ryan, Caroline X. Gao, Kelsey L. Grantham, Lê Thị Phương Thảo, Anaïs Charles‐Nelson, Rhys Alistair Bowden, Alan Herschtal, Katherine J. Lee, Andrew Benjamin Forbes, Stephane R. Heritier et al. · 2024 · International Journal of Eating Disorders
Personalised risk-prediction tools for cryptococcal meningitis mortality to guide treatment stratification in sub-Saharan Africa: a prognostic modelling study based on pooled analysis of two randomised controlled trials
Thomas H. A. Samuels, Síle F. Molloy, David Stephen Lawrence, Angela Loyse, Cecilia Kanyama, Robert S. Heyderman, Wai Shing Lai, Sayoki Mfinanga, Sokoine Lesikari Kivuyo, Duncan M Chanda et al. · 2025 · The Lancet Global Health
Individualised treatment effects of enhanced early mobilisation in mechanically ventilated patients: a secondary analysis of the TEAM trial
Carol Lynette Hodgson, Alexandra B. Spicer, Tessa Broadley, Michael Bailey, Rinaldo Bellomo, Kathy Brickell, Heidi Buhr, Belinda J. Gabbe, Doug William Gould, Meg Harrold et al. · 2025 · Intensive Care Medicine
Explainable AI-driven precision clinical trial enrichment: demonstration of the NetraAI platform with a phase II depression trial
Joseph Geraci, Bessi Qorri, Mike J. Tsay, Christian A. Cumbaa, Paul Leonczyk, Larry D Alphs, Elizabeth D. Ballard, Carlos A. Zarate, Luca Pani · 2025 · npj Digital Medicine
Heterogeneous treatment and spillover effects under clustered network interference
Falco J. Bargagli-Stoffi, Costanza Tortù, Laura Forastiere · 2025 · The Annals of Applied Statistics
Heterogeneous Treatment Effects of Intensive Glycemic Control on Kidney Microvascular Outcomes and Mortality in ACCORD
Vivek Charu, Jane W. Liang, Glenn Matthew Chertow, June Li, Maria E. Montez‐Rath, Pascal Geldsetzer, Ian H. de Boer, Lü Tian, Manjula Kurella Tamura · 2023 · Journal of the American Society of Nephrology
Exploration of different statistical approaches in the comparison of dopamine and norepinephrine in the treatment of shock: SOAP II
Fernando Godinho Zampieri, Sean M. Bagshaw, Hassane Njimi, Jean‐Louis Vincent, Daniel De Backer, SOAP II Investigators, P. Biston, J. Devriendt, C. Madl, D. Chochrad et al. · 2024 · Critical Care
Heterogeneity of Treatment Effects in Clinical Trials: Overview of Multivariable Approaches and Practical Recommendations
Andrea Bellavia, Sabina A. Murphy · 2024 · Circulation
Addressing Systematic Missing Data in the Context of Causally Interpretable Meta-analysis
David Barker, Ruofan Bie, Jon Arni Steingrimsson · 2023 · Prevention Science
Use of multiple covariates in assessing treatment‐effect modifiers: A methodological review of individual participant data meta‐analyses
Peter John Godolphin, Nadine Marlin, Chantelle Cornett, David J. Fisher, Jayne F. Tierney, Ian R. White, Ewelina Rogozińska · 2023 · Research Synthesis Methods
Improving methods of clinical practice guidelines: From guidelines to pathways to fast‐and‐frugal trees and decision analysis to develop individualised patient care
Benjamin Djulbegović, Iztok Hozo, Adam C. Cuker, Gordon Henry Guyatt · 2023 · Journal of Evaluation in Clinical Practice
Risk‐Based Decision Making: Estimands for Sequential Prediction Under Interventions
Kim Luijken, Paweł Morzywołek, Wouter A. C. van Amsterdam, Giovanni Cinà, Jeroen Hoogland, Ruth H. Keogh, Jesse H. Krijthe, Sara Magliacane, Thijs van Ommen, Niels B. Peek et al. · 2024 · Biometrical Journal
Magnitude of effect of low dose colchicine, a newly food and drug administration approved treatment for stroke prevention
Erica Escalera, Jeffrey L. Saver · 2024 · Journal of Stroke and Cerebrovascular Diseases
Low-Dose Aspirin for Individualized Cancer Prevention in Older Adults
Lê Thị Phương Thảo, Tri‐Long Nguyen, Jasmine Singh, Sean Byars, Alexander G. Bick, Leslie G. Ford, Peter Gibbs, John J. McNeil, Anne M. Murray, Suzanne Gaye Orchard et al. · 2025 · JAMA Oncology
Assessing the ability of an instrumental variable causal forest algorithm to personalize treatment evidence using observational data: the case of early surgery for shoulder fracture
John M. Brooks, Cole G. Chapman, Sarah Bauer Floyd, Brian Chen, Charles A. Thigpen, Michael J. Kissenberth · 2022 · BMC Medical Research Methodology
Postdischarge Noninvasive Telemonitoring and Nurse Telephone Coaching Improve Outcomes in Heart Failure Patients With High Burden of Comorbidity
Asher Kimchi, Harriet Udin Aronow, Yu-Ming Ni, Michael K. Ong, James Mirocha, Jeanne T. Black, Andrew David Auerbach, Théodore G. Ganiats, Sheldon Greenfield, Patrick S. Romano et al. · 2022 · Journal of Cardiac Failure
Predicting heterogeneous treatment effects of an Internet-based depression intervention for patients with chronic back pain: Secondary analysis of two randomized controlled trials
Mathias Harrer, David Daniel Ebert, Paula Ricarda Kuper, Sarah Paganini, Sandra Schlicker, Yannik Terhorst, Benedikt Reuter, Lasse Sander, Harald Baumeister · 2023 · Internet Interventions
Widespread Pain Phenotypes Impact Treatment Efficacy Results in Randomized Clinical Trials for Interstitial Cystitis/ Bladder Pain Syndrome: A MAPP Network Study
John T. Farrar, Kenneth Locke, James Quentin Clemens, James William Griffith, Steven E. Harte, Ziya Kırkalı, Karl J. Kreder, John N. Krieger, H. Henry Lai, Robert Moldwin et al. · 2023 · Research Square
Two-step pragmatic subgroup discovery for heterogeneous treatment effects analyses: perspectives toward enhanced interpretability
Toshiaki Komura, Falco J. Bargagli-Stoffi, Koichiro Shiba, Kosuke Inoue · 2025 · European Journal of Epidemiology
Still Searching for Understanding: The Importance of Diverse Research Designs, Methods, and Perspectives
Roberta J. Elman · 2022 · American Journal of Speech-Language Pathology
From Logic-Respecting Efficacy Estimands to Logic-Ensuring Analysis Principle for Time-to-Event Endpoint in Randomized Clinical Trials with Subgroups
Yi Liu, Miao Yang, Siyoen Kil, Jiang Li, Shoubhik Mondal, Yue Shentu, Hong Tian, Liwei Wang, Godwin Yung · 2023 · Statistics in Biopharmaceutical Research
Personalized decision-making for aneurysm treatment of aneurysmal subarachnoid hemorrhage: development and validation of a clinical prediction tool
Jordi de Winkel, Bob Roozenbeek, Simone A. Dijkland, Rúben Dammers, Pieter‐Jan van Doormaal, Mathieu van der Jagt, David V. Klaveren, Diederik W.J. Dippel, Hester Floor Lingsma · 2024 · BMC Neurology
A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2
Catharine I. Paules, Jing Wang, Kay Marie Tomashek, Tyler Bonnett, Kanal Singh, Vincent C. Marconi, Richard T. Davey, David Chien Lye, Lori Elizabeth Dodd, Otto O. Yang et al. · 2024 · Annals of Internal Medicine
Machine Learning–Driven Analysis of Individualized Treatment Effects Comparing Buprenorphine and Naltrexone in Opioid Use Disorder Relapse Prevention
Majid Afshar, Emma J. Graham Linck, Alexandra B. Spicer, John Rotrosen, Elizabeth Salisbury‐Afshar, Pratik Sinha, Matthew W. Semler, Matthew M. Churpek · 2024 · Journal of Addiction Medicine
Predicting Benefit From FOLFOXIRI Plus Bevacizumab in Patients With Metastatic Colorectal Cancer
Marinde J. G. Bond, Maarten van Smeden, Koen Degeling, Chiara Cremolini, Hans‐Joachim Schmoll, Carlotta Antoniotti, Sara Lonardi, Sabina Murgioni, Daniele Rossini, Stefan Ibach et al. · 2024 · JCO Clinical Cancer Informatics
Comparison of Khorana vs. ONKOTEV predictive score to individualize anticoagulant prophylaxis in outpatients with cancer
Chiara Alessandra Cella, Benjamin Djulbegović, Iztok Hozo, Florian Lordick, Vincenzo Bagnardi, Samuele Frassoni, Lorenzo Gervaso, Nicola Fazio · 2024 · European Journal of Cancer
Development and application of predictive clinical biomarkers for low back pain care: recommendations from the ISSLS phenotype/precision spine focus group
Paul W. Hodges, Gwendolyn Sowa, Conor O’Neill, Nam N. Vo, Nadine Elizabeth Foster, Dino Samartzis, Jeffrey C. Lotz · 2025 · European Spine Journal